Deciphera Pharmaceuticals, Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-04-25: Form DEF 14A; Period of report 2024-06-20; Description DEF 14A; Document dcph-20240425.htm.
- 2023-04-26: Form DEF 14A; Description DEF 14A; Document dcph-20230425.htm.
- 2022-04-26: Form DEF 14A; Period of report 2022-06-23; Description DEF 14A; Document dcph-2022xproxystatement.htm.
- 2021-04-29: Form DEF 14A; Period of report 2021-06-23; Description DEF 14A; Document dcph-2021xproxystatement.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-04-25 | DEF 14A | 2024-06-20 | DEF 14A | dcph-20240425.htm |
| 2023-04-26 | DEF 14A | DEF 14A | dcph-20230425.htm | |
| 2022-04-26 | DEF 14A | 2022-06-23 | DEF 14A | dcph-2022xproxystatement.htm |
| 2021-04-29 | DEF 14A | 2021-06-23 | DEF 14A | dcph-2021xproxystatement.htm |
| 2020-04-24 | DEF 14A | 2020-06-10 | DEF 14A | d795887ddef14a.htm |
| 2019-04-22 | DEF 14A | 2019-06-11 | DEF 14A | d686231ddef14a.htm |
| 2018-04-03 | DEF 14A | 2018-05-16 | DEF 14A | d518842ddef14a.htm |